A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
15
Page:
37-47
Author(s):
Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal
A Review on Antiproliferative and Apoptotic Activities of Natural Honey
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
15
Page:
48-56
Author(s):
Saravana Kumar Jaganathan, Arunpandian Balaji, Muthu Vignesh Vellayappan, Manjesh Kumar Asokan, Aruna Priyadharshni Subramanian, Agnes Aruna John, Eko Supriyanto, Saiful Izwan Abd Razak and Mohsen Marvibaigi
The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy
Journal:
Letters in Drug Design & Discovery
Volume:
12
Page:
172-179
Author(s):
Joanna Cytarska, Krzysztof Skowerski, Szymon Jaworski, Konrad Misiura, Beata Filip-Psurska and Joanna Wietrzyk
Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
1166-1172
Author(s):
Surajit Chakraborty, Rajasri Bhattacharyya, Kirtimaan Sayal and Dibyajyoti Banerjee
Oral and Dental Considerations in the Management of Leukemic Children
Journal:
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume:
1
Page:
118-122
Author(s):
Eman H. Alnuaimi, Manal El-Halabi and Mawlood B. Kowash
Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
685-699
Author(s):
You P. Wang, Sha Yi, Lu Wen, Ben P. Zhang, Zichu Zhao, Jing Y. Hu, Fei Zhao, Jing He, Jun Fang, Chun Zhang, Guohui Cui and Yan Chen
Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
Journal:
Current Cancer Therapy Reviews
Volume:
10
Page:
90-96
Author(s):
Aikaterini Bitsani, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Nikolitsa Kafasi, Kalliroi Tsalimalma, Panagiotis Tsaftaridis, Maria M. Angelopoulou, Theodoros P. Vassilakopoulos, Maria Dimou, Tatiana Tzenou, Vasiliki Bartzis, Eftychia Nikolaou, Anna Efthymiou, Ilias Pessach, Vasiliki Karali, Ioanna Vardounioti, Nora-Athina Vyniou, Theodoros Iliakis, Aikaterini Sarris, Dimitrios Maltezas and Efstathios Koulieris
MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
737-751
Author(s):
Hamidreza Maroof, Ali Salajegheh, Robert A. Smith and Alfred K.-Y. Lam
Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
1083-1092
Author(s):
Zichu Zhao and Yan Chen
AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
700-712
Author(s):
Alexandra Schrader, Wagma Popal, Nils Lilienthal, Giuliano Crispatzu, Petra Mayer, Dan Jones, Michael Hallek and Marco Herling